Influence of age on the outcome of antitumour necrosis factor alpha therapy in rheumatoid arthritis

Annals of the Rheumatic Diseases

Volumn 68, Issue 9, 2009, Pages 1470-1473

  Radovits, B J ^a   Kievit, W ^a   Fransen, J ^a   Van De Laar, M A F J ^b   Jansen, T L ^c   Van Riel, P L C M ^a   Laan, R F J M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF TWENTE   (Netherlands)

^c Medisch Centrum   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ETANERCEPT; INFLIXIMAB; METHOTREXATE; PREDNISONE;

ADULT; AGE; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ACTIVITY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG TOLERANCE; DRUG WITHDRAWAL; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; PRIORITY JOURNAL; REMISSION; RHEUMATOID ARTHRITIS; TREATMENT OUTCOME; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

ADULT; AGE FACTORS; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DRUG THERAPY, COMBINATION; HUMANS; LONGITUDINAL STUDIES; MIDDLE AGED; PATIENT DROPOUTS; PRODUCT SURVEILLANCE, POSTMARKETING; REMISSION INDUCTION; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 69949170818     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2008.094730     Document Type: Article

References (16)

1. Central Bureau voor de Statistiek. Population prognostics in the Netherlands 2006-2050. http://www.cbs.nl/nl-NL/menu/themas/dossiers/vergrijzing/ cijfers/ nieuw/default.htm (accessed 10 August 2007).
2. Administration on Aging (AOA). Projections of future growth of the older population. http://www.aoa.gov/AoARoot/Aging-Statistics/future-growth/ future-growth.aspx (accessed May 2009).
3. Kaipiainen-Seppanen O, Aho K, Isomaki H, Laakso M. Shift in the incidence of rheumatoid arthritis toward elderly patients in Finland during 1975-1990. Clin Exp Rheumatol 1996;14:537-542
4. Sesin CA, Bingham COI. Remission in rheumatoid arthritis: wishful thinking or clinical reality? Semin Arthritis Rheum 2005;35:185-196
5. Mavragani CP, Moutsopoulos HM. Rheumatoid arthritis in the elderly. Exp Gerontol 1999;34:463-471
6. Weng NP. Aging of the immune system: how much can the adaptive immune system adapt? Immunity 2006;24:495-499
7. Solana R, Mariani E. NK and NK/T cells in human senescence. Vaccine 2000;18:1613-1620
8. Bathon JM, Fleischmann RM, van der Heijde DM, Tesser JR, Peloso PM, Chon Y, et al. Safety and efficacy of etanercept treatment in elderly subjects with rheumatoid arthritis. J Rheumatol 2006;33:234-243 (Pubitemid 43209297)
9. Fleischmann RM, Baumgartner SW, Tindall EA, Weaver AL, Moreland LW, Schiff MH, et al. Response to etanercept (EnbrelH) in elderly patients with rheumatoid arthritis: a retrospective analysis of clinical trial results. J Rheumatol 2003;30:691-696
10. Fleischmann R, Iqbal I. Risk : benefit profile of etanercept in elderly patients with rheumatoid arthritis, ankylosing spondylitis or psoriatic arthritis. Drugs Aging 2007;24:239-254 (Pubitemid 46457026)
11. Schiff MH, Yu EB, Weinblatt ME, Moreland LW, Genovese MC, White B, et al. Long-term experience with etanercept in the treatment of rheumatoid arthritis in elderly and younger patients - patient-reported outcomes from multiple controlled and open-label extension studies. Drugs Aging 2006;23:167-178
12. Kievit W, Fransen J, Oerlemans AJM, Kuper HH. van der Laar MAFJ, de Rooij DJRAM, et al. The efficacy of anti-TNF in rheumatoid arthritis, a comparison between randomized controlled trials and clinical practice. Ann Rheum Dis 2007;66:1473-1478 (Pubitemid 350032655)
13. Zink A, Strangfeld A, Stoyanova-Scholz M, Wassenberg S, Kapelle A, Schneider M, et al. Patients who are ineligible for clinical trials have lower treatment response in daily practice than those who fulfil standard inclusion criteria. Arthritis Rheum 2006;54:S786-7.
14. Genevay S, Finckh A, Ciurea A, Chamot AM, Kyburz D, Gabay C. Tolerance and effectiveness of anti-tumor necrosis factor alpha therapies in elderly patients with rheumatoid arthritis: a population-based cohort study. Arthritis Rheum 2007;57:679-685
15. Verstappen SMM, Jacobs JWG, van der Veen MJ, Heurkens AHM, Schenk EY, ter Borg EJ, et al. Intensive treatment with methotrexate in early rheumatoid arthritis: aiming for remission. Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA, an open-label strategy trial). Ann Rheum Dis 2007;66:1443-1449
16. Emery P, Salmon M. Early rheumatoid-arthritis - time to aim for remission. Ann Rheum Dis 1995;54:944-947